Industry: Pharmaceuticals, Biotechnology
VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling preclinical activity in both renal and melanoma cancers and VQD-002 which has shown to inhibit the phosphorylation of Akt which can be seen in abnormal levels in breast, ovarian, colorectal, pancreatic, and hematologic ( www.vioquestpharm.com )
VioQuest Pharmaceuticals , Inc.
180 Mt. Airy Road Suite 102
Basking Ridge, New Jersey 07920
USA
Tel: (908) 766-4400
Fax: (908) 766-4455